NewGenIvf Group Limited (NIVF) P/E Ratio History
Historical price-to-earnings valuation from 2024 to 2024
Loading P/E history...
NIVF Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, NewGenIvf Group Limited (NIVF) trades at a price-to-earnings ratio of -0.1x, with a stock price of $1.29 and trailing twelve-month earnings per share of $-0.81.
The current P/E is 100% below its 5-year average of 45.7x. Over the past five years, NIVF's P/E has ranged from a low of 45.7x to a high of 45.7x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, NIVF trades at a 100% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, NIVF trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our NIVF DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
NIVF P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 29.5 | 4.40 | +14% | |
| $6B | 7.7Lowest | 0.23Best | -6% | |
| $7B | 50.3 | - | -4% | |
| $21B | 25.5 | 6.01 | +171%Best |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
NIVF Historical P/E Data (2024–2024)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2024 Q4 | $4860.00 | $106.30 | 45.7x | +0% |
Average P/E for displayed period: 45.7x
See NIVF's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NIVF Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NIVF vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNIVF — Frequently Asked Questions
Quick answers to the most common questions about buying NIVF stock.
Is NIVF stock overvalued or undervalued?
NIVF trades at -0.1x P/E, below its 5-year average of 45.7x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does NIVF's valuation compare to peers?
NewGenIvf Group Limited P/E of -0.1x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is NIVF's PEG ratio?
NIVF PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2024-2024.